Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?
Authors:
- 16 July 2023
- journal article
- research article
- Published by Elsevier in Revue Neurologique
- Vol. 179 (9) , 967-974
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genesJournal of Medical Genetics, 2012
- Randomized, Controlled Crossover Trial of Dronabinol, 2.5 mg, for Agitation in 2 Patients With DementiaJournal of Clinical Psychopharmacology, 2011
- Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trialJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical TrialsAmerican Journal of Hospice and Palliative Medicine®, 2010
- Inflammation in ALS and SMA: Sorting out the good from the evilNeurobiology of Disease, 2010
- Amyotrophic lateral sclerosisOrphanet Journal of Rare Diseases, 2009
- The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetJournal of Neurochemistry, 2007
- Survey of cannabis use in patients with amyotrophic lateral sclerosisAmerican Journal of Hospice and Palliative Medicine®, 2004
- Marijuana in the management of amyotrophic lateral sclerosisAmerican Journal of Hospice and Palliative Medicine®, 2001
- Effects of Dronabinol on anorexia and disturbed behavior in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 1997